William H. Geerts MD (Toronto, CA)
|
Thromboprophylaxis as a key patient safety priority: current approaches and future directions |
Andreas Greinacher MD (Greifswald, DE)
|
Heparin-induced thrombocytopenia |
Helen H. Hobbs MD (Dallas, TX)
|
Cardiovascular genetics |
Philip Hogg PhD (Sidney, AUS)
|
Contibution of allosteric disulfide bonds to regulation of hemostasis |
Shaun Jackson MD PhD (Prahran, AUS)
|
Modern concepts of platelet activation during thrombus development |
Rudolf Jaenisch MD (Cambridge, MA)
|
Stem cells, pluripotency, and nuclear reprogramming |
J. Evan Sadler MD PhD (St Louis, MO)
|
von Willebrand assembly and secretion |